News

Moderna RSV Vaccine Gains Expanded FDA Approval for Younger Adults
Moderna Inc. (NASDAQ:MRNA) is one of the best mid cap growth stocks to invest in now. On June 12, the US FDA expanded the ...
STAT8h
Cassidy calls to delay meeting of CDC’s vaccine panel in challenge to RFK Jr.
WASHINGTON — A key Senate health leader is calling for this week’s meeting of the panel of vaccine advisers handpicked by ...
What to expect from CDC vaccine advisory committee meeting with RFK Jr.'s new members
The Centers for Disease Control and Prevention's vaccine advisory committee is set to meet for the first time since Health ...
CDC's vaccine advisory committee to vote on RSV, flu shots
The U.S. Centers for Disease Control and Prevention panel of vaccine experts will vote on shots for respiratory syncytial ...
Moderna falls on doubts over new CDC panel's backing of RSV vaccine
Moderna's shares fell 2.3% on Friday on concerns about whether a new CDC advisory panel would back the use of the company's ...
Plummeting hospitalizations, healthier babies: East Alabama’s RSV vaccine success
A virus that once filled pediatric hospital beds and terrified new parents is finally being pushed back—before babies are ...
Pulmonology Advisor12h
CDC Vaccine Expert Resigns After RFK Jr Cuts Advisers
Dr Fiona Havers resigned from her role tracking viral epidemics for the CDC due to a lack of confidence in the current leadership.
US CDC Official in Charge of COVID, RSV Data Resigns Ahead of Vaccine Meeting
The scientist, Dr. Fiona Havers, told colleagues at the Centers for Disease Control and Prevention on Monday that she no ...
CDC vaccine advisers to vote on thimerosal in flu shots at first meeting of new panel
A newly posted agenda for next week’s meeting of the just-appointed group of outside vaccine advisers to the US Centers for ...
Moderna falls on fears new CDC vaccine advisory panel could cloud RSV shot prospects
Moderna's shares fell 2.5% before the bell on Friday, on concerns whether a new CDC advisory panel would back the use of the ...
Newly approved antibody could offer another option for protecting infants from RSV, a common infection that can be deadly | CNN
The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 cause of hospitalization in infants.